U.S. Software Stock News

CMS Energy (NYSE:CMS) reported strong Q4 2025 results and raised its 2026 EPS guidance. The company introduced a 20-year plan centered on expanding solar and wind capacity. Management highlighted the long-term shift towards renewable energy alongside financial updates. For investors watching NYSE:CMS, these updates come with the stock at $77.16 and a return of 53.7% over the past 5 years. The recent 9.6% gain year to date and 42.6% return over 3 years show how the share price has moved over...

Tremco, a unit of RPM International (NYSE:RPM), has agreed to acquire Kalzip GmbH. The deal brings Kalzip’s aluminum building envelope systems into RPM’s building solutions portfolio. The acquisition is expected to expand RPM’s reach across Europe, India, and North America. RPM International, through its Tremco segment, focuses on building envelope products such as roofing, waterproofing, and related systems. Adding Kalzip’s metal roofing and façade solutions fits within that core line of...

Omada Health (OMDA) is back in focus after reporting its first GAAP profitable quarter, alongside revenue growth in 2025 and improved margins, while also rolling out its GLP-1 Flex Care program for employers. See our latest analysis for Omada Health. The recent earnings beat, first GAAP profitable quarter and launch of GLP-1 Flex Care have coincided with a 20.6% 1 month share price return. However, the negative 90 day and year to date share price returns suggest momentum has only recently...

If you are wondering whether Corvus Pharmaceuticals' recent share price puts it at a bargain or a stretched level, you are not alone. This article is here to unpack what that current price might mean for value focused investors. The stock has been volatile, with a 7 day return of an 11.7% decline and a 30 day return of a 22.8% decline, set against a year to date return of 115.8% and a 1 year return of 271.6%, plus an increase of more than 7x over 3 years and 381.6% over 5 years. Recent...

Full year 2025 earnings reset the conversation Civitas Resources (CIVI) recently reported full year 2025 results, with revenue of US$4,393 million and net income of US$561 million, both lower than the prior year, putting the stock back under closer investor review. See our latest analysis for Civitas Resources. At a share price of US$27.38, Civitas Resources has seen a 5.0% decline in its 90 day share price return and a 43.4% drop in its 1 year total shareholder return. This suggests momentum...

The Morning Bull - US Market Morning Update Monday, Mar, 9 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 1.3% and Nasdaq 100 futures off roughly 1.5%, as investors react to a jump in borrowing costs and energy prices. The US 10 year Treasury yield is around 4.22%, meaning mortgages, car loans, and corporate borrowing can all stay more expensive for longer, while oil above US$100 keeps pressure on fuel and transport costs. With Middle East...

On February 24, 2026, Brady Corporation’s board declared a US$0.245 per-share dividend on Class A common stock, payable April 30, 2026, to shareholders of record as of April 9, 2026. This dividend decision comes alongside multi-year growth in sales, earnings, and free cash flow, underscoring Brady’s capacity to return cash to investors. We’ll now examine how Brady’s dividend declaration, against a backdrop of solid multi-year earnings and cash flow growth, influences its investment...

In a recent filing, Eva Live announced it secured $7 million in growth financing, another step closer to advancing the company’s broader investment narrative.

Recent share performance and business snapshot With no single headline event driving attention to Veris Residential (VRE), the recent share performance itself is the focus, as the stock shows double digit returns over the past month and past 3 months. Veris Residential is a real estate investment trust focused on Class A multifamily properties in the Northeast. It uses a technology enabled, vertically integrated platform to manage, operate, acquire, and develop its portfolio for residents and...

Certara recently highlighted that its Simcyp physiologically-based pharmacokinetic modeling was accepted by the U.S. FDA in place of multiple clinical pharmacology studies to support the new drug application for asciminib (Scemblix®), an allosteric BCR::ABL1 inhibitor for Chronic Myeloid Leukemia. This decade-long modeling effort, which replaced at least ten dedicated clinical studies and informed dosing and drug-interaction decisions, underscores how biosimulation can cut development costs...

In early March 2026, SES AI Corporation reported full-year 2025 results showing sales of US$21.00 million, a smaller net loss of US$73.04 million, a Q4 revenue shortfall versus expectations, and new 2026 revenue guidance of US$30.00 million to US$35.00 million alongside a projected reset in gross margins. The earnings release also revealed a pivot away from automotive battery mass production toward energy storage systems, drones, and materials, while logistics-driven shipment delays and...

Vulcan Materials (NYSE:VMC) reported quarterly results that came in below expectations, alongside softer guidance for the near term. J.P. Morgan downgraded the stock and flagged the possibility that demand growth could stay subdued until 2027. Short interest in Vulcan Materials has risen, pointing to increased bearish positioning in the shares. Vulcan Materials, trading at $274.99, is coming off a tough stretch, with the stock down 11.3% over the past week and 15.1% over the past month...

In late February and early March 2026, analysts including Citi, Raymond James, and Barclays turned more cautious on American Homes 4 Rent, citing softer rental demand, elevated new supply, and rising concessions across single-family and multifamily markets. At Citi’s Miami Global Property CEO Conference 2026, American Homes 4 Rent outlined its response with a new US$500 million share repurchase authorization and plans to develop about 1,900 homes in 2026 while closely tracking legislative...

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...

In early March 2026, Mobix Labs, Inc. reported new production purchase orders for its high-reliability electromagnetic interference protection components used in Gulfstream business jets and the U.S. Navy’s Tomahawk cruise missile program, alongside a change to its bylaws reducing the shareholder meeting quorum requirement to one-third of voting power. The fresh aerospace and defense orders underline Mobix Labs’ role as an already-qualified supplier embedded in mission-critical platforms...

If you are wondering whether Casella Waste Systems at around US$94.03 is a fair deal or a stretch, you are not alone. This article focuses squarely on what the current price might imply about value. The stock has moved 0.9% over the past week, while showing a 10.1% decline over 30 days, a 4.7% decline year to date, a 16.4% decline over 1 year, but gains of 24.7% over 3 years and 45.3% over 5 years. Recent price moves sit against a backdrop where investors are watching the waste and recycling...

Napco Security Technologies recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, highlighting its electronic security solutions business and long-term roadmap. The company’s focus on high-margin recurring revenue and ongoing analyst interest in its operating performance has put its evolving business model under a brighter spotlight. Next, we’ll examine how this renewed analyst confidence around recurring revenue growth could influence Napco...

C3.ai (NYSE:AI) is under legal scrutiny after shareholders filed lawsuits alleging securities law violations and breaches of fiduciary duty. The actions follow disappointing financial results, a challenging CEO transition, and claims that material adverse information about sales and growth prospects was not properly disclosed. Regulatory and legal investigations are ongoing, raising questions about the company’s governance and leadership oversight. C3.ai, trading at $9.19, is in the...

Clear Secure has partnered with Mount Sinai Health System to roll out its CLEAR1 digital identity platform across one of New York City's largest health systems. The collaboration focuses on improving digital experiences for patients and staff while helping streamline day to day healthcare operations. The move reflects Clear Secure's push beyond travel use cases into healthcare, applying its identity technology in a large scale clinical setting. For investors watching Clear Secure...

Niagen Bioscience recently reported its strongest year to date, with 2025 net sales reaching US$129.4 million, net income of US$17.4 million, and management guiding for 2026 net sales to grow a further 10%–15% year-over-year excluding divested analytical reference standards and services revenue. Alongside this financial progress, the company deepened its intellectual property around nicotinamide riboside injectables and broadened into new categories such as at-home injection kits and...

Lennox International (NYSE:LII) has entered the North American water heating market through a joint venture with Ariston Group. The partnership is launching a new line of water heaters, adding to Lennox's existing product portfolio. The move expands Lennox's dealer network and allows contractors to offer integrated HVAC and water heating solutions. Lennox International, best known for residential and commercial HVAC systems, is now stepping into water heating, a closely related category...

In early March 2026, Omada Health launched its GLP-1 Flex Care program for employer clients and reported fourth-quarter 2025 revenue of US$75.85 million with net income of US$5.16 million, alongside full-year 2025 revenue of US$260.21 million and reduced annual net loss of US$12.78 million. By combining a cash-pay GLP-1 access model that limits employers’ drug spend with improving profitability metrics, Omada is positioning its virtual care platform as both a cost-control and...

Large investors have been actively reshaping their positions in Turning Point Brands (NYSE:TPB) following the company’s move toward nicotine pouches. Apis Capital Advisors has raised its stake, while Cannell Capital has cut its holdings, with both changes occurring soon after a strong earnings report. These moves highlight differing views on the shift from legacy products to modern oral nicotine and the role of nicotine pouches in TPB’s future. Turning Point Brands, trading at $91.66, has...

Red Cat Holdings (NasdaqCM:RCAT) has entered an alliance with Allen Control Systems under the Futures Initiative to integrate AI-powered counter-drone and autonomous weapon solutions. The collaboration extends Red Cat’s technology beyond aerial drones into both air and maritime defense domains. The move positions Red Cat as a broader multi-domain defense technology provider, with potential relevance for government and allied contracts. Red Cat Holdings, trading at $15.36, is drawing...